These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9409197)

  • 21. F2-isoprostanes as markers of oxidant stress: an overview.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.5. PubMed ID: 23045114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion.
    Mori TA; Puddey IB; Burke V; Croft KD; Dunstan DW; Rivera JH; Beilin LJ
    Redox Rep; 2000; 5(1):45-6. PubMed ID: 10905544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoprostanes as oxidant stress markers in coronary reperfusion.
    Meydani M
    Nutr Rev; 1997 Nov; 55(11 Pt 1):404-7. PubMed ID: 9420453
    [No Abstract]   [Full Text] [Related]  

  • 24. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
    Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 8-Isoprostaglandin F2 alpha, a product of lipid peroxidation, increases portal pressure in normal and cirrhotic rats.
    Marley R; Harry D; Anand R; Fernando B; Davies S; Moore K
    Gastroenterology; 1997 Jan; 112(1):208-13. PubMed ID: 8978361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets.
    Leitinger N; Blazek I; Sinzinger H
    Thromb Res; 1997 May; 86(4):337-42. PubMed ID: 9187022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IPF2alpha-I: an index of lipid peroxidation in humans.
    Praticò D; Barry OP; Lawson JA; Adiyaman M; Hwang SW; Khanapure SP; Iuliano L; Rokach J; FitzGerald GA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3449-54. PubMed ID: 9520386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid.
    Liu T; Stern A; Roberts LJ; Morrow JD
    J Biomed Sci; 1999; 6(4):226-35. PubMed ID: 10420080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
    Tacconelli S; Capone ML; Patrignani P
    Methods Mol Biol; 2010; 644():165-78. PubMed ID: 20645173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
    Roberts LJ; Morrow JD
    Ann N Y Acad Sci; 1994 Nov; 744():237-42. PubMed ID: 7825845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
    Ciabattoni G; Davì G; Collura M; Iapichino L; Pardo F; Ganci A; Romagnoli R; Maclouf J; Patrono C
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1195-201. PubMed ID: 11029317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of F2-isoprostane biosynthesis and inhibition in man.
    Davì G; Falco A; Patrono C
    Chem Phys Lipids; 2004 Mar; 128(1-2):149-63. PubMed ID: 15037160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoprostanes and other markers of peroxidation in atherosclerosis.
    Patrignani P; Tacconelli S
    Biomarkers; 2005 Nov; 10 Suppl 1():S24-9. PubMed ID: 16298908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoprostanes and the kidney.
    Badr KF; Abi-Antoun TE
    Antioxid Redox Signal; 2005; 7(1-2):236-43. PubMed ID: 15650411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes.
    Devaraj S; Hirany SV; Burk RF; Jialal I
    Clin Chem; 2001 Nov; 47(11):1974-9. PubMed ID: 11673365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
    Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson JA; Rokach J; Maclouf J; Violi F; FitzGerald GA
    J Clin Invest; 1997 Oct; 100(8):2028-34. PubMed ID: 9329967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats.
    Södergren E; Cederberg J; Basu S; Vessby B
    J Nutr; 2000 Jan; 130(1):10-4. PubMed ID: 10613758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet activation in obese women: role of inflammation and oxidant stress.
    Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
    JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.
    Roberts LJ; Morrow JD
    Free Radic Biol Med; 2000 Feb; 28(4):505-13. PubMed ID: 10719231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isoprostanes, a new substance group in angiology--of future significance?].
    Aghajanian AA; Oguogho A; Sinzinger H
    Vasa; 1997 May; 26(2):65-9. PubMed ID: 9221617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.